<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 3.3e -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: ohrp_09302012.xfr; Date: 2013/01/09T14:56:02 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/DocumentAndEntityInformation" xlink:href="ohrp-20120930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/BalanceSheets" xlink:href="ohrp-20120930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/BalanceSheetsParenthetical" xlink:href="ohrp-20120930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/StatementsOfOperations" xlink:href="ohrp-20120930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/StatementsOfOperationsParenthetical" xlink:href="ohrp-20120930.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/StatementsOfStockholdersEquityDeficit" xlink:href="ohrp-20120930.xsd#StatementsOfStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/StatementsOfCashFlows" xlink:href="ohrp-20120930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/DescriptionOfBusiness" xlink:href="ohrp-20120930.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ohrp-20120930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/PatentCosts" xlink:href="ohrp-20120930.xsd#PatentCosts" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/NotesPayable" xlink:href="ohrp-20120930.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/DerivativeLiabilityAndFairValueMeasurements" xlink:href="ohrp-20120930.xsd#DerivativeLiabilityAndFairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/CapitalStock" xlink:href="ohrp-20120930.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/CommonStockWarrants" xlink:href="ohrp-20120930.xsd#CommonStockWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/CommonStockOptions" xlink:href="ohrp-20120930.xsd#CommonStockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/CommitmentsAndContingencies" xlink:href="ohrp-20120930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/SubsequentEvents" xlink:href="ohrp-20120930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ohrp-20120930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="ohrp-20120930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/CommonStockWarrantsTables" xlink:href="ohrp-20120930.xsd#CommonStockWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/CommonStockOptionsTables" xlink:href="ohrp-20120930.xsd#CommonStockOptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="ohrp-20120930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="ohrp-20120930.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:href="ohrp-20120930.xsd#SummaryOfSignificantAccountingPoliciesDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/PatentCostsDetailsNarrative" xlink:href="ohrp-20120930.xsd#PatentCostsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/NotesPayableDetailsNarrative" xlink:href="ohrp-20120930.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/DerivativeLiabilityAndFairValueMeasurementsDetailsNarrative" xlink:href="ohrp-20120930.xsd#DerivativeLiabilityAndFairValueMeasurementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/CapitalStockDetailsNarrative" xlink:href="ohrp-20120930.xsd#CapitalStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/CommonStockWarrantsDetailsNarrative" xlink:href="ohrp-20120930.xsd#CommonStockWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/CommonStockWarrantsDetails" xlink:href="ohrp-20120930.xsd#CommonStockWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/CommonStockOptionsDetailsNarrative" xlink:href="ohrp-20120930.xsd#CommonStockOptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/CommonStockOptionsDetails" xlink:href="ohrp-20120930.xsd#CommonStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://ohrpharmaceutical.com/role/SubsequentEventsDetailsNarrative" xlink:href="ohrp-20120930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/DocumentAndEntityInformation" xlink:title="0001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/BalanceSheets" xlink:title="0002 - Statement - Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_ohrpAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Cash" xlink:label="loc_ohrpCash" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpAssetsCurrent" xlink:to="loc_ohrpCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_ohrpPrepaidExpenseCurrent" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpAssetsCurrent" xlink:to="loc_ohrpPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GrantsReceivableCurrent" xlink:label="loc_ohrpGrantsReceivableCurrent" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpAssetsCurrent" xlink:to="loc_ohrpGrantsReceivableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_ohrpOtherAssetsCurrent" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpAssetsCurrent" xlink:to="loc_ohrpOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Assets" xlink:label="loc_ohrpAssets" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpAssets" xlink:to="loc_ohrpAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_ohrpPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpAssets" xlink:to="loc_ohrpPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ohrp-20120930.xsd#ohrp_PatentCostsNet" xlink:label="loc_ohrpPatentCostsNet" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpAssets" xlink:to="loc_ohrpPatentCostsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_ohrpLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_ohrpAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpLiabilitiesCurrent" xlink:to="loc_ohrpAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_ohrpDerivativeLiabilitiesCurrent" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpLiabilitiesCurrent" xlink:to="loc_ohrpDerivativeLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_ohrpNotesPayableCurrent" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpLiabilitiesCurrent" xlink:to="loc_ohrpNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_ohrpLiabilities" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpLiabilities" xlink:to="loc_ohrpLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_ohrpStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_ohrpPreferredStockValue" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpStockholdersEquity" xlink:to="loc_ohrpPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_ohrpCommonStockValue" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpStockholdersEquity" xlink:to="loc_ohrpCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_ohrpAdditionalPaidInCapital" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpStockholdersEquity" xlink:to="loc_ohrpAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:label="loc_ohrpCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpStockholdersEquity" xlink:to="loc_ohrpCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_ohrpRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpStockholdersEquity" xlink:to="loc_ohrpRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:label="loc_ohrpDevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" />
      <link:calculationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpStockholdersEquity" xlink:to="loc_ohrpDevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_ohrpLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpLiabilitiesAndStockholdersEquity" xlink:to="loc_ohrpLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpLiabilitiesAndStockholdersEquity" xlink:to="loc_ohrpStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/BalanceSheetsParenthetical" xlink:title="0003 - Statement - Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/StatementsOfOperations" xlink:title="0004 - Statement - Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_ohrpOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_ohrpGeneralAndAdministrativeExpense" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpOperatingExpenses" xlink:to="loc_ohrpGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_ohrpResearchAndDevelopmentExpense" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpOperatingExpenses" xlink:to="loc_ohrpResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_ohrpProfessionalFees" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpOperatingExpenses" xlink:to="loc_ohrpProfessionalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_SalariesAndWages" xlink:label="loc_ohrpSalariesAndWages" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpOperatingExpenses" xlink:to="loc_ohrpSalariesAndWages" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_ohrpOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_ohrpGrossProfit" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpOperatingIncomeLoss" xlink:to="loc_ohrpGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpOperatingIncomeLoss" xlink:to="loc_ohrpOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_ohrpNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_ohrpInterestExpense" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNonoperatingIncomeExpense" xlink:to="loc_ohrpInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="loc_ohrpGainLossOnDerivativeInstrumentsNetPretax" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNonoperatingIncomeExpense" xlink:to="loc_ohrpGainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_ohrpGainLossOnDispositionOfAssets" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNonoperatingIncomeExpense" xlink:to="loc_ohrpGainLossOnDispositionOfAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_ohrpOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNonoperatingIncomeExpense" xlink:to="loc_ohrpOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_ohrpGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNonoperatingIncomeExpense" xlink:to="loc_ohrpGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_ohrpIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_ohrpIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_ohrpIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_ohrpIncomeTaxExpenseBenefit" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_ohrpIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_ohrpIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:label="loc_ohrpDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="loc_ohrpDiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:label="loc_ohrpDiscontinuedOperationTaxEffectOfDiscontinuedOperation" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="loc_ohrpDiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_ohrpNetIncomeLoss" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNetIncomeLoss" xlink:to="loc_ohrpIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNetIncomeLoss" xlink:to="loc_ohrpIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/StatementsOfOperationsParenthetical" xlink:title="0005 - Statement - Statements of Operations (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/StatementsOfStockholdersEquityDeficit" xlink:title="0006 - Statement - Statements of Stockholders' Equity (Deficit)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/StatementsOfCashFlows" xlink:title="0007 - Statement - Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_ohrpNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_ohrpProceedsFromSaleOfProductiveAssets" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_ohrpProceedsFromSaleOfProductiveAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_ohrpPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_ohrpPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_ohrpPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_ohrpPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:label="loc_ohrpProceedsFromDivestitureOfBusinesses" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_ohrpProceedsFromDivestitureOfBusinesses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_ohrpNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_ohrpProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ohrpProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_ohrpProceedsFromIssuanceOrSaleOfEquity" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ohrpProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_ohrpProceedsFromWarrantExercises" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ohrpProceedsFromWarrantExercises" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_ohrpProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ohrpProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_ohrpRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ohrpRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_ohrpProceedsFromNotesPayable" />
      <link:calculationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ohrpProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_ohrpRepaymentsOfNotesPayable" />
      <link:calculationArc order="700" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ohrpRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2012/elts/us-gaap-2012-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="loc_ohrpRepaymentsOfConvertibleDebt" />
      <link:calculationArc order="800" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ohrpNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ohrpRepaymentsOfConvertibleDebt" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/DescriptionOfBusiness" xlink:title="0008 - Disclosure - DESCRIPTION OF BUSINESS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="0009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/PatentCosts" xlink:title="0010 - Disclosure - PATENT COSTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/NotesPayable" xlink:title="0011 - Disclosure - NOTES PAYABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/DerivativeLiabilityAndFairValueMeasurements" xlink:title="0012 - Disclosure - DERIVATIVE LIABILITY AND FAIR VALUE MEASUREMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/CapitalStock" xlink:title="0013 - Disclosure - CAPITAL STOCK" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/CommonStockWarrants" xlink:title="0014 - Disclosure - COMMON STOCK WARRANTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/CommonStockOptions" xlink:title="0015 - Disclosure - COMMON STOCK OPTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/CommitmentsAndContingencies" xlink:title="0016 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/SubsequentEvents" xlink:title="0017 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="0018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="0019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/CommonStockWarrantsTables" xlink:title="0020 - Disclosure - COMMON STOCK WARRANTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/CommonStockOptionsTables" xlink:title="0021 - Disclosure - COMMON STOCK OPTIONS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="0022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="0023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:title="0024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/PatentCostsDetailsNarrative" xlink:title="0025 - Disclosure - PATENT COSTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/NotesPayableDetailsNarrative" xlink:title="0026 - Disclosure - NOTES PAYABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/DerivativeLiabilityAndFairValueMeasurementsDetailsNarrative" xlink:title="0027 - Disclosure - DERIVATIVE LIABILITY AND FAIR VALUE MEASUREMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/CapitalStockDetailsNarrative" xlink:title="0028 - Disclosure - CAPITAL STOCK (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/CommonStockWarrantsDetailsNarrative" xlink:title="0029 - Disclosure - COMMON STOCK WARRANTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/CommonStockWarrantsDetails" xlink:title="0030 - Disclosure - COMMON STOCK WARRANTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/CommonStockOptionsDetailsNarrative" xlink:title="0031 - Disclosure - COMMON STOCK OPTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/CommonStockOptionsDetails" xlink:title="0032 - Disclosure - COMMON STOCK OPTIONS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://ohrpharmaceutical.com/role/SubsequentEventsDetailsNarrative" xlink:title="0033 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
